Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 38Neoplasm Metastasis 16Leukemia, Myeloid, Acute 13Skin Neoplasms 10Kidney Neoplasms 10Leukemia 9Carcinoma, Renal Cell 9Neoplasms 7Ovarian Neoplasms 6Breast Neoplasms 6Lymphoma, Non-Hodgkin 5Lymphoma 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Myelodysplastic Syndromes 4Congenital Abnormalities 4Neuroblastoma 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia, Lymphocytic, Chronic, B-Cell 3Carcinoma, Non-Small-Cell Lung 3Uterine Cervical Neoplasms 2Recurrence 2Papillomavirus Infections 2Pancreatic Neoplasms 2Lymphoma, Mantle-Cell 2Hodgkin Disease 2Fallopian Tube Neoplasms 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Breast Neoplasms, Male 2Waldenstrom Macroglobulinemia 1

Interventions

fludarabine phosphate 2aldesleukin 2Cyclophosphamide 2fludarabine 1Whole-Body Irradiation 1Interleukin-2 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Melanoma, Experimental × Interleukin-2 × Clear all
NCT00513604 2013-06-03

Phase II Study of Short-Term Cultured Anti-Tumor Autologous Lymphocytes After Lymphocyte-Depleting Chemotherapy in Metastatic Melanoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
158 enrolled 14 charts
Dermatologic

Melanoma, Melanoma, Experimental, Neoplasms, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡